Claims
- 1. An implantable three-dimensional device or a standalone bioreactor or device for anatomical, histological and spatial inter-reaction of one or several types of cells, cell clusters or tissues, said device comprising:
a) a support layer; and b) a multiplicity, from one to several thousands, of containment layers comprising a multiplicity of wells interconnected horizontally within one containment layer, vertically or through inclined microfluidic channels with other containment layers.
- 2. The device of claim 1 additionally comprising one or more permanent or removable masking layers for cell deposition into the wells of the containment layers, said masking layers comprising openings having a pattern corresponding to several or all wells positioned on the containment layer immediately below the masking layer.
- 3. The device of claim 2 wherein the support layer is fabricated of glass, silicon, hardened polymer, titanium, film or porous material having a smooth or etched surface.
- 4. The device of claim 3 wherein said support layer additionally comprises a gated or nongated inlet port and a gated or nongated outlet port and wherein said support layer is flat or have a rising edge or a rim to form a containment structure comprising a containment cavity for emplacement of a multiplicity of containment layers within said cavity.
- 5. The device of claim 4 comprising the multiplicity of containment layers emplaced within the containment cavity of the support layer.
- 6. The device of claim 5 wherein the containment layer is fabricated from a biocompatible biodegradable material, a biodegradable hydrogel, or a rigid nonbiodegradable material.
- 7. The device of claim 6 wherein said rigid nonbiodegradable material is a glass, Pyrex, quartz, diamond-like carbon, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal or polymer;
wherein said biodegradable material is a polymer, polylactic acid (PLA), polyglycolic acid (PGA), copolymer of both poly (lacticglycolic) acid (PLGA), poly-β-hydroxybutyrate (PHB), polyanhydride, polyorthoester, polycaprolactone, polycarbonate, polyfumarate or polymethylmethacrylate; and wherein said biodegradable hydrogel is collagen, collagen-glycosaminoglycan (GAG) copolymer, Type I collagen-κ elastin, alginate, calcium alginate, hyaluronan, methacrylated alginate, hyaluronan or agarose.
- 8. The device of claim 7 wherein said containment layer is surface modified with a mechanical, physical or chemical modification wherein said modification comprises a formation of channels, canals, ducts, conduits, tubes and utilizes masking techniques, plasma surface treatments, biological coating using polysaccharides, proteins, peptides, polymers, or glycoproteins, covalent linkages of peptides, integrins, nucleic acid, saccharides, lipopolysaccharides or amino acids, micromachining, wet or dry lithographic etching, plasma fluorine-based plasma etching, reactive ion etching, sputtering, plating, chemical and vapor deposition, physical vapor deposition and photoresist.
- 9. The device of claim 8 wherein said wells have a size from about 1 micron to about 5 millimeters, a depth from about 0.1 microns to 1 millimeter, and have a square, rectangular, oval, round or triangular shape and wherein a distance between the wells is from about 0.1 microns to about 3 millimeters.
- 10. The device of claim 9 wherein said wells are coated with an adhesive material selected from the group consisting of a protein, peptide, fibronectin, vitronectin, growth factor, poly-D-lysine or a peptide containing specific cell recognition sequences or with repulsive material selected from the group consisting of octodecyltrichlorosilane, polyethyleneglycol of molecular weight from 5,000 to 100,000, albumine or serum proteins.
- 11. The device of claim 10 wherein the microfluidic channel is a canal, conduit or tube of a diameter from about 1 to about 200 microns and a length of up to about 5 mm, wherein said channel connects the wells positioned on the same or different containment layers and permits the flow of cellular metabolites, hormones, proteins, water, nutrients, media or other solutions between the wells and layers.
- 12. The device of claim 11 wherein said microfluidic channels are equipped to establish, maintain and control a chemical, electrical or pressure potential, optical wave guide or ultrasound between the wells or between the support layer and the containment layer or between the support layer and the wells, or wherein said microfluidic channels permit build-up of osmotic gradient from the inlet port to the outlet port.
- 13. The device of claim 12 wherein said masking layer is removable.
- 14. The device of claim 13 wherein the removable masking layer is used for deposition of cells into the wells within the containment layers.
- 15. The device of claim 14 wherein the material used for fabrication of the masking layer is a glass, Pyrex, quartz, diamond-like carbon, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal or polymer;
wherein said biodegradable material is a polymer, polylactic acid (PLA), polyglycolic acid (PGA), copolymer of both poly (lacticglycolic) acid (PLGA), poly-β-hydroxybutyrate (PHB), polyanhydride, polyorthoester, polycaprolactone, polycarbonate, polyfumarate or polymethylmethacrylate; and wherein said biodegradable hydrogel is collagen, collagen-glycosaminoglycan (GAG) copolymer, Type I collagen-κ elastin, alginate, calcium alginate, hyaluronan, methacrylated alginate, hyaluronan or agarose.
- 16. The device of claim 15 wherein said masking layer comprises a multiplicity of openings, holes, perforations or slits distributed within said masking layer in a masking pattern corresponding to a pattern in which the wells are distributed within a containment layer into which the cells are deposited.
- 17. The device of claim 16 wherein for the cell deposition the openings on the masking layer are positioned directly above the well of the containment layer.
- 18. The device of claim 17 wherein said multiple containment layers with deposited cells within the wells are assembled and enclosed within the support layer cavity.
- 19. A method for the functional interaction and regulation of the same or different types of cells within a three-dimensional implantable device or within a stand-alone bioreactor or device, said method comprising steps:
a) fabricating a support layer, a multiplicity of containment layers comprising wells and one or several masking layers; b) depositing the same or different types of cells within the wells of the same or different containment layer of said device using the masking layers; c) assembling the containment layers of step b) into a three-dimensional structure within the support layer thereby generating a three-dimensional device; d) introducing a buffer, saline, water, blood, serum or medium into the microfluidic channels interconnecting the individual wells through microfluidic channels; and e) determining functionality of cells by measuring levels and production of cytokines, chemokines, growth factors, hormones, enzymes, metabolites, catabolites, proteins, peptides, nucleic acid, carbohydrates or lipids, or a combination thereof.
- 20. The method of claim 19 wherein the support layer is fabricated of glass, silicon, hardened polymer, titanium grade screen, film or porous material having a smooth or etched surface, Pyrex, quartz, diamond-like carbon, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal or polymer;
wherein said support layer additionally optionally comprises a gated or nongated inlet port and a gated or nongated outlet port; and wherein said support layer is flat or have rising edges or a rim to form a containment structure comprising a containment cavity for emplacement of one or several containment layers within said containment cavity.
- 21. The method of claim 20 wherein said containment layer is fabricated from a biocompatible biodegradable material, a biodegradable hydrogel or a rigid nonbiodegradable material selected from the group consisting of a glass, Pyrex, quartz, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal, biocompatible polymer, polylactic acid (PLA), polyglycolic acid (PGA), copolymer of bothpoly (lacticglycolic) acid (PLGA), poly-β-hydroxybutyrate (PHB), polyanhydride, polyorthoester, polycaprolactone, polycarbonate, polyfumarate, polymethylmethacrylate, Type II collagen-glycosaminoglycan (GAG) copolymer, Type I collagen-κ elastin, alginate, calcium alginate, hyaluronan, methacrylated variation of alginates, hyaluronan and agarose.
- 22. The method of claim 21 wherein said containment layer is further surface modified with a mechanical, physical or chemical modification wherein said modification comprises a formation of channels, canals, ducts, conduits, tubes, utilizing masking techniques, plasma surface treatments, biological coating using polysaccharides, proteins, peptides, polymers, glycoproteins, covalent linkages of peptides, integrins, nucleic acid, saccharides, lipopolysaccharides or amino acids, micromachining, wet or dry lithographic etching, plasma fluorine-based plasma etching, reactive ion etching, sputtering, plating, chemical and vapor deposition, physical vapor deposition and photoresist.
- 23. The method of claim 22 wherein said wells positioned on said containment layer have a size from about 1 micron to about 5 millimeters and a depth from about 0.1 microns to about 1 millimeter, wherein said wells have a square, rectangular, oval, round or triangular shape and wherein a distance between the wells is from about 0.1 microns to about 3 millimeters.
- 24. The method of claim 23 wherein said wells are coated with a cell-specific adhesive or repulsive material selected from the group consisting of protein, peptide, fibronectin, vitronectin, growth factor, poly-D-lysine or a peptide containing specific cell recognition sequences permitting adhesion of cells to the wells during the cell deposition step.
- 25. The method of claim 24 wherein the microfluidic channel is a canal, conduit or tube of a diameter from about 1 to about 200 microns and length of up to about 5 mm, wherein said channel connects the wells positioned on different containment layers and permits the flow of cellular metabolites, catabolites hormones, proteins, peptides or nutrients secreted by the cells deposited within the wells.
- 26. The method of claim 25 wherein said microfluidic channels are equipped to establish, maintain and control a chemical, electrical or pressure potential or optical wave guide or ultrasound between wells or between the support layer and containment layer or between the support layer and wells or wherein said microfluidic channels permit build-up of osmotic gradient from the inlet port to the outlet port.
- 27. The method of claim 26 wherein the cell are deposited into the wells through a removable masking layer which is removed following the cell deposition through masking layers openings.
- 28. The method of claim 27 wherein said masking layer comprises a multiplicity of openings, holes, perforations or slits distributed within said masking layer in a masking pattern corresponding to a pattern in which the wells are distributed within the containment layer immediately below the masking layer into which the cells are deposited.
- 29. The method of claim 28 wherein for the cell deposition the openings on the masking layer are positioned directly above the well of the containment layer and wherein said cells are deposited in the wells directly under pressure, by centrifugation, suction, spraying, inkjet printing, spin-on in a centrifuge, electrical gradient or wherein the cells are deposited by injecting the appropriate microfluidic channel with a cell suspension under pressure, centrifugation, suction, spraying, inkjet printing, spin-on in a centrifuge or by electrical gradient.
- 30. The method of claim 29 wherein said multiple containment layers with deposited cells within the wells are enclosed within the containment cavity and products of cell metabolism or cell-cell interaction are removed through the outlet port and tested.
- 31. A process for fabricating a three-dimensional device comprises steps of:
a) fabricating a support layer; b) fabricating a containment layer; c) fabricating a masking layer; d) depositing cells on the containment layer; and e) assembling the three-dimensional device.
- 32. The process of claim 31 wherein in step a) said support layer is flat or have rising edges or a rim to form a containment structure comprising a containment cavity for emplacement of one or several containment layers within thus formed cavity and wherein said support layer is fabricated from a glass, silicon, hardened polymer, titanium grade screen, Pyrex, quartz, diamond-like carbon, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal or polymer, film or porous material having a smooth or etched surface.
- 33. The process of claim 32 wherein the step a) further comprises attachment of a gated or nongated inlet port and a gated or nongated outlet port to said support layer, wherein said port is attached to the top, to the bottom or to the side of the support layer.
- 34. The process of claim 33 wherein the step b comprises fabrication of one or more containment layers comprising multiplicity of wells interconnected horizontally with microfluidic channels within one containment layer or vertically or with inclined microfluidic channels with other containment layers or with the support layer.
- 35. The process of claim 34 comprising fabrication of individual containment layers each comprised of wells coated with an adhesive material permitting a deposition of the same or different type of cells within wells of each containment layer.
- 36. The process of claim 35 wherein the containment layer is fabricated from a biocompatible biodegradable material, a biodegradable hydrogel, or a rigid nonbiodegradable material.
- 37. The process of claim 36 wherein said nonbiodegradable material is a glass, Pyrex, quartz, silicon, polydimethylsiloxane, biocompatible silicone based polymer, nonbiodegradable biocompatible metal or polymer wafer, and wherein said biodegradable material is a polymer, polyactic acid (PLA), polyglycolic acid (PGA), copolymer of both poly (lacticglycolic) acid (PLGA), poly-β-hydroxybutyrate (PHB), polyanhydride, polyorthoester, polycaprolactone, polycarbonate, polyfumarate or polymethylmethacrylate wafer and wherein said biodegradable hydrogel is collagen, collagenglycosaminoglycan (GAG) copolymer, Type I collagen-κ elastin, alginate, calcium alginate, hyaluronan, methacrylated variation of alginates, hyaluronan or agarose.
- 38. The process of claim 37 further comprising a surface modification of the containment layer with a mechanical, physical or chemical modification which modification comprises a formation of channels, canals, ducts, conduits, tubes, utilizing masking techniques, plasma surface treatments, biological coating using polysaccharides, proteins, peptides, polymers, or glycoproteins, covalent linkages of peptides, integrins, nucleic acid, saccharides, lipopolysaccharides, or amino acids, micromachining, wet or dry lithographic etching, plasma fluorine-based plasma etching, reactive ion etching, sputtering, plating, chemical and vapor deposition, physical vapor deposition and photoresist.
- 39. The process of claim 38 wherein said surface modification of said containment layer comprises formation of wells having sizes from about 1 micron to about 5 millimeters and depth from about 1 millimeter to 0.1 microns and having a square, rectangular, oval, round or triangle shape wherein a distance between the wells is from about 0.1 microns to about 3 millimeters.
- 40. The process of claim 39 wherein in step b) said wells are coated with an adhesive material selected from protein, peptide, fibronectin, vitronectin, growth factor, poly-D-lysine or a peptide containing specific cell recognition sequences to provide adhesion of the cells to the wells.
- 41. The process of claim 40 further including a formation of the microfluidic channels wherein a channel is a canal, conduit or tube of about 1 to about 200 microns diameter and up to about 5 mm length, wherein said channel connects the wells positioned on different containment layers and permits the flow of cellular metabolites, hormones, proteins, peptides or nutrients.
- 42. The process of claim 41 wherein said microfluidic channel is fabricated to be equipped with an entity permitting establishment, maintenance and control of chemical, electrical or pressure potential between the individual wells or between the support layer and the containment layer or between the support layer and the wells or where said microfluidic channel permits build-up of osmotic gradient from the inlet port to the outlet port.
- 43. The process of claim 42 wherein step c) comprises fabrication of one or more masking layers for cell deposition into the wells of the containment layers, said masking layers comprising openings having a pattern corresponding to several or all wells positioned on the containment layer immediately below the masking layer.
- 44. The process of claim 43 wherein said masking layers are fabricated for a permanent or removable use.
- 45. The process of claim 44 wherein the removable masking layer is fabricated of material which is removable by peeling it off the containment layer after the deposition of cells into the wells within the containment layer.
- 46. The process of claim 45 wherein the material used for fabrication of the masking layer is a glass, Pyrex, quartz, diamond-like carbon, silicon, polydimethylsiloxane, biocompatible silicone based polymer, biocompatible metal or polymer;
wherein said biodegradable material is a polymer, polylactic acid (PLA), polyglycolic acid (PGA), copolymer of both poly (lacticglycolic) acid (PLGA), poly-β-hydroxybutyrate (PHB), polyanhydride, polyorthoester, polycaprolactone, polycarbonate, polyfumarate or polymethylmethacrylate; and wherein said biodegradable hydrogel is collagen, collagen-glycosaminoglycan (GAG) copolymer, Type I collagen-κ elastin, alginate, calcium alginate, hyaluronan, methacrylated alginate, hyaluronan or agarose.
- 47. The process of claim 46 wherein said masking layer comprises a multiplicity of openings, holes, perforations or slits distributed within said masking layer in a masking pattern corresponding to a pattern in which the wells are distributed within the containment layer into which the cells are deposited.
- 48. The process of claim 47 wherein for the cell deposition the openings on the masking layer are positioned directly above the well of the containment layer.
- 49. The process of claim 48 comprising, in step d), assembling of multiple containment layers with deposited cells within the wells into the three-dimensional device and wherein the wells and containment layers are interconnected through the microfluidic channels.
- 50. An implantable three-dimensional device fabricated from biocompatible or biodegradable material, or a combination of both, said device comprising a multiplicity of containment layers, said layers comprising a multiplicity of wells seeded with cells, cell clusters or tissue, said wells further interconnected vertically, horizontally or inclined through microchannels filled with a medium, buffer, water, blood, serum or other solution, said containment layers enclosed within a support layer comprising an inlet and an outlet, or both.
- 51. The device of claim 50 suitable for temporary or permanent replacement or tissue or organs.
- 52. A three-dimensional bioreactor device for production of cellular products, said bioreactor fabricated from biocompatible or biodegradable material, or a combination of both, said bioreactor device comprising a multiplicity of containment layers, said layer comprising a multiplicity of wells seeded with at lest two different types of cells, cell clusters or tissue, said wells interconnected vertically, horizontally or in incline through microchannels filled with a medium, saline, buffer, water, blood, serum or other solution, said containment layers enclosed within a support layer comprising an inlet and an outlet, or both.
- 53. The bioreactor of claim 52 wherein the cellular products are products of cell metabolism, proteins or hormones.
Parent Case Info
[0001] This invention is based on and claims priority of he Provisional application Ser. No. 60/291,814 filed on May 17, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60291814 |
May 2001 |
US |